(Q35611848)

9 August 2017

1 reference

title

Rituximab (Rituxan/MabThera): the first decade (1993-2003). (English)

1 reference

9 August 2017

1 reference

Antonio J Grillo-López

series ordinal

1 reference

9 August 2017

publication date

1 December 2003

1 reference

Expert Review of Anticancer Therapy

9 August 2017

published in

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

9 August 2017

page(s)

767-779

1 reference

No Initial Therapy for Stage III and IV Non-Hodgkin's Lymphomas of Favorable Histologic Types

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.6.767

Response criteria for NHL: importance of 'normal' lymph node size and correlations with response rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.6.767

Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.6.767

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.6.767

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.6.767

21 January 2018

Identifiers

DOI

10.1586/14737140.3.6.767

1 reference

release_6ubj5gev3zgzfaub2mxlaa34fm

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6ubj5gev3zgzfaub2mxlaa34fm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference